BioSpace News Archive

Biotech Bay

Bio-Rad Launches Reliance One-Step Multiplex Supermix for Pathogen Detection and High-Throughput Screening

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the Reliance One-Step Multiplex Supermix, a highly sensitive and robust reagent mix for detection and quantification of up to five RNA or DNA targets in one reaction.

July 31, 2019
·
3 min read
Drive for generics sees Korea increasingly attractive to international pharma

Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.

July 31, 2019
·
4 min read
Deals

GHO Capital Announces the Sale of Caprion Biosciences

Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, announces the sale of Caprion Biosciences to Arsenal Capital Partners, a leading specialized private equity firm that invests in middle-market healthcare and specialty industrials companies.

July 31, 2019
·
3 min read
Global Cardiac Arrhythmias Therapeutics Market 2019-2023 | Advent of Gene Therapy to Boost Growth | Technavio

The global cardiac arrhythmias therapeutics market is expected to post a CAGR of more than 4% during the period 2019-2023, according to the latest market research report by Technavio.

July 31, 2019
·
4 min read
Policy

REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich’s Ataxia Using NAV® AAV9 Vector

REGENXBIO Inc., a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, announced it entered into a license agreement with Pfizer Inc.

July 31, 2019
·
5 min read
Business

BioInvent Announces Selection of First Target Discovered by BioInvent’s Proprietary F.I.R.S.TTM Technology Platform Under Collaboration With Pfizer Inc.

BioInvent International AB announces that Pfizer Inc. has selected the first target under the companies’ cancer immunotherapy research collaboration and license agreement, into which the companies entered in December 2016 to develop antibodies targeting tumor-associated myeloid cells.

July 31, 2019
·
3 min read
Biotech Bay

BioTime Announces Name Change to Lineage Cell Therapeutics

BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced it is launching a new corporate brand, including a change of its corporate name to Lineage Cell Therapeutics, Inc., effective August 12, 2019

July 31, 2019
·
5 min read
Business

NeuroPace Appoints Mark Saxton as Vice President of Sales

Industry veteran to drive business development, strategy and enhance customer experience

July 31, 2019
·
4 min read
Global ENT Laser Devices Market 2019-2023| 6% CAGR Projection Over the Next Five Years| Technavio

The global ENT laser devices market is expected to post a CAGR of more than 6% during the period 2019-2023, according to the latest market research report by Technavio.

July 31, 2019
·
4 min read
Business

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its second quarter and year-to-date 2019 financial results on Wednesday, August 7, 2019, before the opening of the U.S. financial markets.

July 31, 2019
·
1 min read